Jerusalem-based Brainsway Ltd. is at the forefront of developing and selling advanced noninvasive neurostimulation treatments that are geared towards mental health disorders. Boasting a global presence, the company offers cutting-edge Deep Transcranial Magnetic Stimulation platform technology that targets a broad range of conditions that range from major depressive disorders, anxious depression, and obsessive-compulsive disorders, to smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. With an impressive customer base that includes doctors, hospitals, and medical centers in psychiatry, Brainsway Ltd. continues to be a trailblazer in the field of mental health treatment since its founding in 2003.
BrainsWay's ticker is BWAY
The company's shares trade on the NASDAQ stock exchange
They are based in Jerusalem, Israel
There are 51-200 employees working at BrainsWay
It is brainsway.com
BrainsWay is in the Healthcare sector
BrainsWay is in the Medical Appliances & Equipment industry
The following five companies are BrainsWay's industry peers: